Authors: | Shah, M. H.; Goldner, W. S.; Halfdanarson, T. R.; Bergsland, E.; Berlin, J. D.; Halperin, D.; Chan, J.; Kulke, M. H.; Benson, A. B. 3rd; Blaszkowsky, L. S.; Eads, J.; Engstrom, P. F.; Fanta, P.; Giordano, T.; He, J.; Heslin, M. J.; Kalemkerian, G. P.; Kandeel, F.; Khan, S. A.; Kidwai, W. Z.; Kunz, P. L.; Kuvshinoff, B. W. 2nd; Lieu, C.; Pillarisetty, V. G.; Saltz, L.; Sosa, J. A.; Strosberg, J. R.; Sussman, C. A.; Trikalinos, N. A.; Uboha, N. A.; Whisenant, J.; Wong, T.; Yao, J. C.; Burns, J. L.; Ogba, N.; Zuccarino-Catania, G. |
Article Title: | NCCN Guidelines® Insights: Neuroendocrine and adrenal tumors, version 2.2018: Featured updates to the NCCN Guidelines |
Abstract: | The NCCN Guidelines for Neuroendocrine and Adrenal Tumors provide recommendations for the management of adult patients with neuroendocrine tumors (NETs), adrenal gland tumors, pheochromocytomas, and paragangliomas. Management of NETs relies heavily on the site of the primary NET. These NCCN Guidelines Insights summarize the management options and the 2018 updates to the guidelines for locoregional advanced disease, and/or distant metastasis originating from gastrointestinal tract, bronchopulmonary, and thymus primary NETs. © JNCCN-Journal of the National Comprehensive Cancer Network. |
Journal Title: | Journal of the National Comprehensive Cancer Network |
Volume: | 16 |
Issue: | 6 |
ISSN: | 1540-1405 |
Publisher: | Harborside Press |
Date Published: | 2018-06-01 |
Start Page: | 693 |
End Page: | 702 |
Language: | English |
DOI: | 10.6004/jnccn.2018.0056 |
PROVIDER: | scopus |
PUBMED: | 29891520 |
DOI/URL: | |
Notes: | Review -- Export Date: 1 August 2018 -- Source: Scopus |